Quick answer
Both medicines are GLP‑1 receptor agonists approved in Australia for chronic weight management. Wegovy (semaglutide) is injected once weekly and generally leads to greater average weight loss than Saxenda (liraglutide), which is injected once daily. Head‑to‑head clinical data show semaglutide produced roughly double the average weight loss versus liraglutide alongside lifestyle support. Your choice should balance effectiveness, dosing preference, tolerability, medical history and availability.
- Wegovy (weekly): stronger average weight loss in trials, weekly convenience, similar GLP‑1 side effect profile
- Saxenda (daily): long‑standing option with daily titration, may suit those preferring smaller day‑to‑day dose steps or when Wegovy supply is constrained
Key differences at a glance
- Active ingredient: Wegovy contains semaglutide; Saxenda contains liraglutide.
- Dosing schedule: Wegovy is once weekly; Saxenda is once daily.
- Titration: Wegovy typically escalates from 0.25 mg weekly to 2.4 mg weekly; Saxenda from 0.6 mg daily to 3 mg daily, if tolerated.
- Effectiveness: Trials report larger average weight loss with semaglutide than with liraglutide when combined with diet and activity changes.
- Side effects: Similar GLP‑1 class effects (nausea, vomiting, diarrhoea/constipation). Slow titration and dietary changes help tolerability.
- Access in Australia: Both require prescription. Neither medicine is PBS‑subsidised for weight management at time of writing. Private cost and supply vary.
Dosing schedules and how they feel week to week
Wegovy (semaglutide) weekly
- Typical titration: 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg weekly, with increases about every 4 weeks if tolerated.
- Convenience: One injection day each week; missing a dose window requires specific catch‑up advice from your prescriber.
- Practical tips: Many people choose a consistent “Wegovy day” and set reminders. Smaller, slower meals reduce nausea during up‑titration.
Saxenda (liraglutide) daily
- Typical titration: 0.6 mg → 1.2 mg → 1.8 mg → 2.4 mg → 3.0 mg daily, with weekly step‑ups if tolerated.
- Flexibility: Daily dosing can feel more routine for some and allows smaller day‑to‑day dose steps.
- Practical tips: Take at the same time each day. If side effects occur, clinicians often hold a dose longer before increasing.
Effectiveness: average weight loss
In clinical trials with lifestyle support:
- Semaglutide 2.4 mg weekly (Wegovy) has produced average weight loss around 12–15% of body weight across major studies, with some people achieving more.
- Liraglutide 3 mg daily (Saxenda) has produced average weight loss around 6–8% of body weight in large trials.
- Head‑to‑head data (semaglutide 2.4 mg vs liraglutide 3 mg) reported substantially greater average weight loss with semaglutide over ~68 weeks.
Individual results vary based on adherence, dose tolerance, baseline weight and accompanying diet, activity, sleep and medications.
Side effects and safety considerations
Both medicines share GLP‑1 class effects. The most common reactions are nausea, vomiting, diarrhoea, constipation, reduced appetite and abdominal discomfort—usually most noticeable during dose increases.
Ways clinicians often improve tolerability
- Slower dose escalations or temporary dose holds if symptoms appear
- Smaller, slower meals; lower fat portions; adequate hydration
- Review of interacting medicines and reflux management if needed
Warnings and when to seek medical advice
- Personal/family history of medullary thyroid carcinoma or MEN2: discuss contraindications
- History of pancreatitis, severe gastrointestinal disease or gallbladder issues
- Pregnancy, planning pregnancy or breastfeeding: weight‑loss medicines are not recommended
- Severe or persistent abdominal pain, signs of dehydration, or allergic reaction: seek urgent care
For detailed effects, read: Wegovy Side Effects and Saxenda Side Effects.
Cost and availability in Australia
- Prescription status: Both require a valid Australian prescription.
- PBS: Neither Wegovy nor Saxenda is PBS‑subsidised for weight management at time of writing; private prices vary by pharmacy and dose.
- Supply: Availability can fluctuate. Your prescriber or pharmacy can advise current stock and expected wait times.
Pricing resources: Wegovy Cost Australia and Saxenda Cost Australia.
Who might consider each option?
Wegovy may suit if you:
- Prefer once‑weekly dosing for convenience and adherence
- Seek greater average weight loss based on trial data
- Can access supply and tolerate up‑titration
Saxenda may suit if you:
- Prefer smaller daily dose steps or want a longer‑established option
- Experience access constraints with Wegovy
- Do well with a daily routine and close dose‑response adjustments
Also compare Mounjaro vs Wegovy, Wegovy vs Mounjaro Weight Loss and Saxenda vs Ozempic.
Switching between Saxenda and Wegovy
- Do not combine two GLP‑1s. Switching is typically done by stopping one and starting the other on a prescriber‑directed schedule.
- Common approach: stop Saxenda and begin Wegovy at the starter dose on your chosen weekly day, but only under clinician guidance.
- Expect a renewed titration period; side effect patterns can change when swapping medicines and schedules.
For access details, read Wegovy Prescription Australia and Saxenda Prescription Australia.
Alternatives to compare
- Ozempic Australia Guide (semaglutide brand indicated for type 2 diabetes; off‑label weight use is restricted during shortages)
- Mounjaro Australia Guide (tirzepatide dual GIP/GLP‑1)
- Rybelsus Australia Guide (oral semaglutide)
- Weight Loss Injections Australia (overview of GLP‑1 and newer dual/triple agonists)
- GLP‑1 Australia Guide (mechanisms, brands and safety)
Frequently asked questions
Is Wegovy more effective than Saxenda?
On average, yes. Trials have shown larger mean weight loss with semaglutide 2.4 mg weekly compared with liraglutide 3 mg daily when combined with lifestyle changes. Individual responses vary.
Which is easier to take: weekly or daily injections?
Many people prefer weekly for convenience, while others like the routine and smaller step‑ups of daily dosing. Adherence and tolerability matter more than the schedule alone.
Are side effects different between Wegovy and Saxenda?
They share GLP‑1 class effects. Nausea is common during dose increases. Slower titration and dietary adjustments improve tolerability for both.
Are Wegovy or Saxenda covered by the PBS for weight loss?
At time of writing, neither is PBS‑subsidised for weight management. Private prices vary by pharmacy and dose strength.
Can I switch from Saxenda to Wegovy?
Yes, with medical supervision. Your prescriber will advise how to stop one, start the other and retitrate safely.
How long until I notice results?
Appetite changes often appear during titration. Clinically meaningful weight change is usually judged over 12–16 weeks and beyond, once a stable, tolerable dose is reached.
Do I need lifestyle changes as well?
Yes. Diet quality, protein intake, fibre, activity, sleep and stress strongly influence outcomes and side effect control.
What about diabetes medicines or other conditions?
If you have type 2 diabetes, hypoglycaemia risk and medication interactions must be reviewed. Always involve your doctor before starting or switching therapies.
Where can I read more?
See Wegovy Australia Guide, Saxenda Australia Guide, and our Weight Loss Injections Australia overview.
Ask for help comparing Wegovy and Saxenda
Share a few details and a clinician‑supported team can guide you on eligibility, dosing schedules, side effects and next steps with an Australian provider.
Final takeaway
Wegovy vs Saxenda is primarily weekly vs daily dosing and higher vs moderate average weight loss. Both can support meaningful weight reduction when paired with lifestyle changes. Your best choice should consider effectiveness, dosing preference, tolerability, medical history, cost and current availability in Australia.